Elevated homocysteine is associated with reduced regional left ventricular function: the Multi-Ethnic Study of

Khurram Nasir1, Michael Tsai, Boaz D Rosen

  • 1Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.

Circulation
|January 4, 2007
PubMed

Insights

Elevated homocysteine (Hcy) levels are linked to reduced regional left ventricular systolic function in asymptomatic individuals. This finding suggests Hcy may impact heart health even before symptoms appear.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Imaging

Background:

  • Elevated homocysteine (Hcy) is a potential risk factor for congestive heart failure.
  • Previous studies suggest a link between Hcy and heart disease in specific populations.

Purpose of the Study:

  • To investigate the association between homocysteine levels and regional left ventricular function.
  • To assess cardiac function in an asymptomatic population using advanced imaging techniques.

Main Methods:

  • Utilized tagged magnetic resonance imaging (MRI) on 1178 participants from the Multi-Ethnic Study of Atherosclerosis (MESA).
  • Calculated regional peak systolic midwall circumferential strains, defining left ventricular regions by coronary territories.
  • Adjusted for traditional cardiovascular risk factors, demographics, and measures of atherosclerosis.

Main Results:

  • Reduced regional myocardial circumferential shortening was observed in the left anterior descending and left circumflex territories in relation to plasma Hcy levels.
  • Circumferential systolic dysfunction showed a significant association with elevated log-transformed Hcy levels in these regions.
  • Increased odds of reduced left ventricular strains were found with higher Hcy levels across all analyzed coronary artery regions.

Conclusions:

  • Elevated homocysteine levels are associated with diminished regional left ventricular systolic function in an asymptomatic cohort.
  • Tagged MRI can detect subtle reductions in cardiac function related to Hcy.
  • These findings highlight Hcy as a potential biomarker for subclinical cardiac impairment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...